加拿大卫生部批准首例新冠病毒抗体的血清学测试

2020-05-14 张森 央视新闻

加拿大卫生部声明,血清学测试将有助于更好地了解曾感染新冠病毒的人是否对该病毒具有免疫力,并在当地时间5月12日晚批准了该国第一例新冠病毒抗体的血清学测试。

加拿大卫生部官网截图

加拿大总理特鲁多当地时间5月13日上午在例行讲话中宣布,加拿大卫生部已经在当地时间12日晚批准了该国第一例新冠病毒抗体的血清学测试。

加拿大卫生部的声明说:“血清学测试将有助于更好地了解曾感染新冠病毒的人是否对该病毒具有免疫力。”“进一步的研究还将帮助我们充分了解抗体阳性测试与防止再次感染的关系。”换言之,血清学测试可以让研究人员知道,新冠病毒感染者康复后,是否能对新冠病毒产生抗体。同时,将帮助科学家确定一个人携带新冠病毒抗体,会不会再次感染新冠病毒。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1771550, encodeId=82b81e71550f8, content=<a href='/topic/show?id=213033009ec' target=_blank style='color:#2F92EE;'>#加拿大卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33009, encryptionId=213033009ec, topicName=加拿大卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58fa38314021, createdName=rebeccajiejie, createdTime=Mon May 25 11:43:49 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2016433, encodeId=040f2016433a2, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70948, encryptionId=d93ee0948f6, topicName=病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Thu Jun 11 00:43:49 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005029, encodeId=29e620050290b, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58067, encryptionId=45605806e8f, topicName=新冠病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Fri Feb 19 11:43:49 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312652, encodeId=aa811312652d4, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443359, encodeId=9842144335906, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36676, encryptionId=d2d0366e60a, topicName=卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538e5060306, createdName=12498e67m29暂无昵称, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468978, encodeId=954514689e82f, content=<a href='/topic/show?id=52f089381e5' target=_blank style='color:#2F92EE;'>#血清学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89381, encryptionId=52f089381e5, topicName=血清学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43126964261, createdName=jjjiang0201, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028030, encodeId=fc8a1028030d4, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Thu May 14 13:43:49 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1771550, encodeId=82b81e71550f8, content=<a href='/topic/show?id=213033009ec' target=_blank style='color:#2F92EE;'>#加拿大卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33009, encryptionId=213033009ec, topicName=加拿大卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58fa38314021, createdName=rebeccajiejie, createdTime=Mon May 25 11:43:49 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2016433, encodeId=040f2016433a2, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70948, encryptionId=d93ee0948f6, topicName=病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Thu Jun 11 00:43:49 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005029, encodeId=29e620050290b, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58067, encryptionId=45605806e8f, topicName=新冠病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Fri Feb 19 11:43:49 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312652, encodeId=aa811312652d4, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443359, encodeId=9842144335906, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36676, encryptionId=d2d0366e60a, topicName=卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538e5060306, createdName=12498e67m29暂无昵称, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468978, encodeId=954514689e82f, content=<a href='/topic/show?id=52f089381e5' target=_blank style='color:#2F92EE;'>#血清学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89381, encryptionId=52f089381e5, topicName=血清学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43126964261, createdName=jjjiang0201, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028030, encodeId=fc8a1028030d4, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Thu May 14 13:43:49 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1771550, encodeId=82b81e71550f8, content=<a href='/topic/show?id=213033009ec' target=_blank style='color:#2F92EE;'>#加拿大卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33009, encryptionId=213033009ec, topicName=加拿大卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58fa38314021, createdName=rebeccajiejie, createdTime=Mon May 25 11:43:49 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2016433, encodeId=040f2016433a2, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70948, encryptionId=d93ee0948f6, topicName=病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Thu Jun 11 00:43:49 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005029, encodeId=29e620050290b, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58067, encryptionId=45605806e8f, topicName=新冠病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Fri Feb 19 11:43:49 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312652, encodeId=aa811312652d4, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443359, encodeId=9842144335906, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36676, encryptionId=d2d0366e60a, topicName=卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538e5060306, createdName=12498e67m29暂无昵称, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468978, encodeId=954514689e82f, content=<a href='/topic/show?id=52f089381e5' target=_blank style='color:#2F92EE;'>#血清学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89381, encryptionId=52f089381e5, topicName=血清学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43126964261, createdName=jjjiang0201, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028030, encodeId=fc8a1028030d4, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Thu May 14 13:43:49 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1771550, encodeId=82b81e71550f8, content=<a href='/topic/show?id=213033009ec' target=_blank style='color:#2F92EE;'>#加拿大卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33009, encryptionId=213033009ec, topicName=加拿大卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58fa38314021, createdName=rebeccajiejie, createdTime=Mon May 25 11:43:49 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2016433, encodeId=040f2016433a2, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70948, encryptionId=d93ee0948f6, topicName=病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Thu Jun 11 00:43:49 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005029, encodeId=29e620050290b, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58067, encryptionId=45605806e8f, topicName=新冠病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Fri Feb 19 11:43:49 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312652, encodeId=aa811312652d4, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443359, encodeId=9842144335906, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36676, encryptionId=d2d0366e60a, topicName=卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538e5060306, createdName=12498e67m29暂无昵称, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468978, encodeId=954514689e82f, content=<a href='/topic/show?id=52f089381e5' target=_blank style='color:#2F92EE;'>#血清学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89381, encryptionId=52f089381e5, topicName=血清学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43126964261, createdName=jjjiang0201, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028030, encodeId=fc8a1028030d4, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Thu May 14 13:43:49 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1771550, encodeId=82b81e71550f8, content=<a href='/topic/show?id=213033009ec' target=_blank style='color:#2F92EE;'>#加拿大卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33009, encryptionId=213033009ec, topicName=加拿大卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58fa38314021, createdName=rebeccajiejie, createdTime=Mon May 25 11:43:49 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2016433, encodeId=040f2016433a2, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70948, encryptionId=d93ee0948f6, topicName=病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Thu Jun 11 00:43:49 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005029, encodeId=29e620050290b, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58067, encryptionId=45605806e8f, topicName=新冠病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Fri Feb 19 11:43:49 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312652, encodeId=aa811312652d4, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443359, encodeId=9842144335906, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36676, encryptionId=d2d0366e60a, topicName=卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538e5060306, createdName=12498e67m29暂无昵称, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468978, encodeId=954514689e82f, content=<a href='/topic/show?id=52f089381e5' target=_blank style='color:#2F92EE;'>#血清学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89381, encryptionId=52f089381e5, topicName=血清学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43126964261, createdName=jjjiang0201, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028030, encodeId=fc8a1028030d4, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Thu May 14 13:43:49 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1771550, encodeId=82b81e71550f8, content=<a href='/topic/show?id=213033009ec' target=_blank style='color:#2F92EE;'>#加拿大卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33009, encryptionId=213033009ec, topicName=加拿大卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58fa38314021, createdName=rebeccajiejie, createdTime=Mon May 25 11:43:49 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2016433, encodeId=040f2016433a2, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70948, encryptionId=d93ee0948f6, topicName=病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Thu Jun 11 00:43:49 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005029, encodeId=29e620050290b, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58067, encryptionId=45605806e8f, topicName=新冠病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Fri Feb 19 11:43:49 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312652, encodeId=aa811312652d4, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443359, encodeId=9842144335906, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36676, encryptionId=d2d0366e60a, topicName=卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538e5060306, createdName=12498e67m29暂无昵称, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468978, encodeId=954514689e82f, content=<a href='/topic/show?id=52f089381e5' target=_blank style='color:#2F92EE;'>#血清学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89381, encryptionId=52f089381e5, topicName=血清学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43126964261, createdName=jjjiang0201, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028030, encodeId=fc8a1028030d4, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Thu May 14 13:43:49 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1771550, encodeId=82b81e71550f8, content=<a href='/topic/show?id=213033009ec' target=_blank style='color:#2F92EE;'>#加拿大卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33009, encryptionId=213033009ec, topicName=加拿大卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58fa38314021, createdName=rebeccajiejie, createdTime=Mon May 25 11:43:49 CST 2020, time=2020-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2016433, encodeId=040f2016433a2, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70948, encryptionId=d93ee0948f6, topicName=病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Thu Jun 11 00:43:49 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005029, encodeId=29e620050290b, content=<a href='/topic/show?id=45605806e8f' target=_blank style='color:#2F92EE;'>#新冠病毒抗体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58067, encryptionId=45605806e8f, topicName=新冠病毒抗体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Fri Feb 19 11:43:49 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312652, encodeId=aa811312652d4, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33006, encryptionId=1aa333006b4, topicName=加拿大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=279b407, createdName=shanyongle, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443359, encodeId=9842144335906, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36676, encryptionId=d2d0366e60a, topicName=卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538e5060306, createdName=12498e67m29暂无昵称, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1468978, encodeId=954514689e82f, content=<a href='/topic/show?id=52f089381e5' target=_blank style='color:#2F92EE;'>#血清学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89381, encryptionId=52f089381e5, topicName=血清学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43126964261, createdName=jjjiang0201, createdTime=Sat May 16 01:43:49 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028030, encodeId=fc8a1028030d4, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Thu May 14 13:43:49 CST 2020, time=2020-05-14, status=1, ipAttribution=)]
    2020-05-14 公卫新人

    新冠肺炎,疫情何时才能消失

    0

相关资讯

羊驼抗体可能有助于对抗COVID-19

如今,研究人员发现另一种盟友——羊驼,它血液中的抗体有助于消灭新冠病毒。

新冠病毒抗体检测,你知道对疫情防控有多重要吗?

扎破手指,取一滴血滴在检测卡样本孔内,再滴加稀释液,15分钟后便可通过观察检测线出现与否,判断自己是否曾经感染新冠病毒。这种与广泛应用的艾滋病检测试剂盒原理类似的新冠抗体快速检测试剂盒,最近成为英法德

有了新冠病毒的抗体,就安全了吗?

随着新冠病毒的"全球化”, 居家、断航、甚至封城封国已在全世界很多国家间出现,人民的生活受到了前所未有的限制,社交距离,不能聚会,居家隔离等等措施让社会,经济活动与公共卫生相关事

JACC:KCNQ1抗体在体内可作为IKs通道的激动剂

长QT综合征(LQTS)患者有发生致命性心律失常的风险,该疾病的一个重要特征就是心脏复极的延迟。药物治疗、植入式心律转复除颤器和左心交感神经切断是目前治疗方案的一部分,但迄今为止还没有针对LQTS的靶

J Gastroenterology: 肽353抗体可作为小儿克罗恩氏病的诊断标志物

据报道,各种血清学标志物,例如抗糖蛋白2抗体和抗酿酒酵母抗体,在克罗恩氏病中可用于诊断。目前,有人提出,针对克罗恩氏病肽353(一种新提出的血清学标志物)的抗体在日本成年人中比抗酵母菌更有用。

湖北:新冠病毒核酸、抗体检测5月6日起纳入医保支付

日前,湖北省医疗保障局下发通知,将新型冠状病毒核酸检测、新型冠状病毒抗体检测项目临时纳入我省基本医疗保险诊疗目录,按乙类支付,自5月6日起在全省正式执行。